Bristol Myers Squibb Co (BMY) insider trading
Every open-market stock purchase and sale by Bristol Myers Squibb Co executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Cristian Massacesi (VP) and 1 other sold $437K in the last 90 days.
- Last insider buy: Samit Hirawat (VP), $202K, 17 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.3M (3 sales). Last close $63.64 on Sep 11, 2026.
Recent BMY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | Cristian Massacesi (VP) | Sold | $403K |
| Sep 1, 2026 | Bartie Wendy Short (VP) | Sold (not open market) | $42.4K |
| Sep 1, 2026 | Bartie Wendy Short (VP) | Bought (not open market) | — |
| Aug 25, 2026 | Phil M Holzer (VP) | Sold | $33.8K |
| Aug 1, 2026 | Cristian Massacesi (VP) | Sold (not open market) | $1.7M |
| Aug 1, 2026 | Cari Gallman (VP) | Sold (not open market) | $35.5K |
| Aug 1, 2026 | Cristian Massacesi (VP) | Bought (not open market) | — |
| Aug 1, 2026 | Cari Gallman (VP) | Bought (not open market) | — |
| Jun 15, 2026 | Julia A Haller (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Bartie Wendy Short (VP) | Sold (not open market) | $212K |
| Jun 3, 2026 | Bartie Wendy Short (VP) | Bought (not open market) | — |
| May 1, 2026 | Adam Lenkowsky (C-suite exec) | Sold (not open market) | $34.9K |
| May 1, 2026 | Adam Lenkowsky (C-suite exec) | Bought (not open market) | — |
| May 1, 2026 | Adam Lenkowsky (C-suite exec) | Sold (not open market) | — |
| Apr 1, 2026 | David V Elkins (CFO) | Sold | $1.6M |
| Apr 1, 2026 | David V Elkins (CFO) | Sold | $278K |
| Apr 1, 2026 | Karin Shanahan (VP) | Sold (not open market) | $104K |
| Apr 1, 2026 | Karin Shanahan (VP) | Bought (not open market) | — |
| Mar 31, 2026 | Theodore R. Samuels II (Director) | Bought (not open market) | $51.2K |
| Mar 31, 2026 | Derica W Rice (Director) | Bought (not open market) | $38.8K |
| Mar 31, 2026 | Peter J Arduini (Director) | Bought (not open market) | $35K |
| Mar 31, 2026 | Phyllis R Yale (Director) | Bought (not open market) | $35K |
| Mar 31, 2026 | Michael R. McMullen (Director) | Bought (not open market) | $35K |
| Mar 10, 2026 | Christopher S. Boerner (CEO) | Sold (not open market) | $632K |
| Mar 10, 2026 | David V Elkins (CFO) | Sold (not open market) | $616K |
Who's trading BMY
- Cristian Massacesi, VP: sold $403K (1 sale), last Sep 9, 2026
- Bartie Wendy Short, VP: other filings, last Sep 1, 2026
- Phil M Holzer, VP: sold $33.8K (1 sale), last Aug 25, 2026
- Cari Gallman, VP: other filings, last Aug 1, 2026
- Julia A Haller, Director: other filings, last Jun 15, 2026
- Adam Lenkowsky, C-suite exec: other filings, last May 1, 2026
- David V Elkins, CFO: sold $1.9M (2 sales), last Apr 1, 2026
- Karin Shanahan, VP: other filings, last Apr 1, 2026
- Phyllis R Yale, Director: other filings, last Mar 31, 2026
- Michael R. McMullen, Director: other filings, last Mar 31, 2026
- Derica W Rice, Director: other filings, last Mar 31, 2026
- Theodore R. Samuels II, Director: other filings, last Mar 31, 2026
- Peter J Arduini, Director: other filings, last Mar 31, 2026
- Hiroshi Chris Shibutani, C-suite exec: other filings, last Mar 10, 2026
- Benjamin Hickey, President: other filings, last Mar 10, 2026
Get free alerts when an insider at Bristol Myers Squibb Co files a new trade →